Induced Ferroptosis Pathway by Regulating Cellular Lipid Peroxidation With Peroxynitrite Generator for Reversing "Cold" Tumors
- PMID: 39279600
- DOI: 10.1002/smll.202404807
Induced Ferroptosis Pathway by Regulating Cellular Lipid Peroxidation With Peroxynitrite Generator for Reversing "Cold" Tumors
Abstract
Overcoming the resistance of tumor cells to apoptosis and immunosuppression is an important challenge to improve tumor immunotherapy. Non-apoptotic death mode of ferroptosis has been regarded as a new strategy to enhance tumor immunotherapy against drug-resistant cancers. The lethal accumulation of lipid peroxides (LPO) determines the progress of ferroptosis. The high susceptibleness of ferroptosis provides an opportunity for combating triple-negative breast cancer. Reactive nitrogen species (RNS) produced by nitric oxide (NO) and reactive oxygen species (ROS) is more lethal than ROS for tumor cells. Herein, an RNS-mediated immunotherapy strategy for inducing ferroptosis pathway is proposed by improving LPO accumulation, and constructed a multifunctional liposome (Lipo-MT-SNAP) comprised of peroxynitrite (ONOO-) generator, tumor targeted group, inhibiting glutathione peroxidase 4 (GPX4), and basic units (dipalmitoyl phosphatidylcholine and cholesterol). The significant enhancement of LPO resulted from the intense oxidative damage of ONOO- impaired synthesis of GPX4 by depleting glutathione, which further amplified ferroptosis and triggered immunogenic cell death. In vivo, RNS-mediated photoimmunotherapy can promote polarization of M2 to M1 macrophages and dendritic cells maturation, further infiltrate T cells, regulate the secretion of inflammatory factors, and reprogram the tumor microenvironment. The powerful RNS-mediated ferroptosis induces strong immunogenicity and effectively inhibit tumor proliferation.
Keywords: ferroptosis; lipid peroxidation; liposome; peroxynitrite; self‐assembly.
© 2024 Wiley‐VCH GmbH.
Similar articles
-
A ferroptosis amplifier based on triple-enhanced lipid peroxides accumulation strategy for effective pancreatic cancer therapy.Biomaterials. 2024 Sep;309:122574. doi: 10.1016/j.biomaterials.2024.122574. Epub 2024 Apr 21. Biomaterials. 2024. PMID: 38670032
-
Targeted Ferroptosis-Immunotherapy Synergy: Enhanced Antiglioma Efficacy with Hybrid Nanovesicles Comprising NK Cell-Derived Exosomes and RSL3-Loaded Liposomes.ACS Appl Mater Interfaces. 2024 Jun 5;16(22):28193-28208. doi: 10.1021/acsami.4c04604. Epub 2024 May 22. ACS Appl Mater Interfaces. 2024. PMID: 38776411 Free PMC article.
-
Carrageenan-ferrocene-eicosapentaenoic acid composite hydrogel induce ferroptosis and apoptosis for anti-tumor recurrence and metastasis.Int J Biol Macromol. 2024 Sep;276(Pt 2):133942. doi: 10.1016/j.ijbiomac.2024.133942. Epub 2024 Jul 16. Int J Biol Macromol. 2024. PMID: 39025181
-
[Research progress on ferroptosis regulation in tumor immunity of hepatocellular carcinoma].Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Dec 25;53(6):715-725. doi: 10.3724/zdxbyxb-2024-0117. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 39694527 Free PMC article. Review. Chinese.
-
GPX4 at the Crossroads of Lipid Homeostasis and Ferroptosis.Proteomics. 2019 Sep;19(18):e1800311. doi: 10.1002/pmic.201800311. Epub 2019 May 31. Proteomics. 2019. PMID: 30888116 Review.
Cited by
-
Targeting ferroptosis: a promising avenue for ovarian cancer treatment.Front Immunol. 2025 Jun 5;16:1578723. doi: 10.3389/fimmu.2025.1578723. eCollection 2025. Front Immunol. 2025. PMID: 40539051 Free PMC article. Review.
-
Potential role of SIRT1 in cell ferroptosis.Front Cell Dev Biol. 2025 Mar 5;13:1525294. doi: 10.3389/fcell.2025.1525294. eCollection 2025. Front Cell Dev Biol. 2025. PMID: 40109363 Free PMC article. Review.
References
-
- a) X. Wang, X. Zhu, B. Li, X. Wei, Y. Chen, Y. Zhang, Y. Wang, W. Zhang, S. Liu, Z. Liu, W. Zhai, P. Zhu, Y. Gao, Z. Chen, ACS Appl. Mater. Interfaces. 2022, 14, 23152;
-
- b) X. Yang, M. Zhao, Z. Wu, C. Chen, Y. Zhang, L. Wang, Q. Guo, Q. Wang, S. Liang, S. Hu, Y. Duan, Y. Sun, ACS Nano 2022, 16, 3417;
-
- c) Y. Cheng, Q. Chen, Z. Guo, M. Li, X. Yang, G. Wan, H. Chen, Q. Zhang, Y. Wang, ACS Nano 2020, 14, 15161.
-
- G. Bianchini, J. M. Balko, I. A. Mayer, M. E. Sanders, L. Gianni, Nat. Rev. Clin. Oncol. 2016, 13, 674.
-
- a) M. Shen, C. Chen, Q. Guo, Q. Wang, J. Liao, L. Wang, J. Yu, M. Xue, Y. Duan, J. Zhang, Adv. Sci. 2022, 9, 2203523;
Publication types
MeSH terms
Substances
Grants and funding
- 22177065/National Natural Science Foundation of China
- U21A6004/National Natural Science Foundation of China
- 202101030201022/Science and Technology Major Project of Shanxi
- YDZJSX2022A003/Central Guide Local Science and Technology Development Found Project of Shanxi Provincial
- 1331/Fund for Shanxi "1331" Project
LinkOut - more resources
Full Text Sources